CoChat

Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications

Open access
Zhang, Xueli, Zhao, Yi, Chen, Shuobing, Shao, Hua · 2021 · Journal of Cachexia, Sarcopenia and Muscle
Cited by 92

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Sarcopenia, characterized by loss of skeletal muscle mass, quality, and strength, has become a common hallmark of ageing and many chronic diseases. Diabetes mellitus patients have a higher prevalence of sarcopenia, which greatly aggravates the metabolic disturbance and compromises treatment response. Preclinical and clinical studies have shown differential impacts of anti‐diabetic drugs on skeletal muscle mass, strength, and performance, highlighting the importance of rational therapeutic regimen from the perspective of sarcopenia risk. In this review, we provide an update on the regulation of muscle mass and quality by major anti‐diabetic drugs, focusing primarily on emerging data from clinical studies. We also discuss the underlying mechanisms and clinical implications for optimal selection of anti‐diabetic drugs to reduce the risk of sarcopenia. In view of the lifelong use of anti‐diabetic drugs, we propose that a better understanding of the sarcopenia risk and interventional strategies is worthy of attention in future studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcsm.12838

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 92

Metadata

Authors
Zhang, X., Zhao, Y., Chen, S., & Shao, H.
Venue
Journal of Cachexia, Sarcopenia and Muscle
Publisher
Wiley
Published
2021-10-21
Volume
12
Issue
6
Pages
1368-1379
ISSN
  • 2190-5991 (ISSN-L)
  • 2190-6009
OpenAlex
W3207613937
Cited by
92
References
27
FWCI
6.40
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications. https://app.cochat.ai/papers/10.1002/jcsm.12838
The paper
Zhang, X., Zhao, Y., Chen, S., & Shao, H. (2021). Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.12838

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.